CEVA Animal Health has launched Diarsanyl Plus, a new intestinal support paste for dogs, cats and small animals containing prebiotics.
Diarsanyl Plus contains the same unique combination of ingredients as Diarsanyl - montmorillonite, Na+, Mg2+ and K+ ions and dextrose - but now also contains prebiotics called fructo-oligosaccharides (FOS).
According to the company, montmorillonite maintains intestinal function by coating and protecting the enterocytes and absorbing toxins, Na+, Mg2+ and K+ ions help maintain electrolyte levels and dextrose provides a much needed energy source for the small intestine. The prebiotics help maintain normal intestinal flora by promoting the growth of good bacteria such as bifidobacteria and lactobacilli and stimulating the production of short chain fatty acids (SCFAs) - acetate, propionate and butyrate - which are important energy sources for the large intestine.
Fraser Broadfoot, product manager at CEVA Animal Health said: "Diarsanyl Plus will build on the proven efficacy of Diarsanyl by including prebiotics that naturally balance the intestinal flora of animals with digestive upsets and diarrhoea. The new easy-to-use syringes and palatable formulation will also make it easier for pet owners to administer."
Diarsanyl Plus is available in 10ml, 24ml and 60ml pack sizes for a variety of species, from small animals to large dogs.
For further information, please contact your CEVA Animal Health representative or call 01494 781510.
Invicta Animal Health has launched SynVet-50, a licensed synthetic Sodium Hyaluronate (HA), for intra-articular treatment of lameness caused by joint dysfunction associated with non-infectious synovitis in horses.
The product is Invicta's first licensed medicine.
According to the company, the functional mechanisms of HA are directly dependent on the molecular weight and concentration of HA. 1 Therefore, SynVet-50 has been formulated with a molecular weight of 1.5m Daltons which is the highest of any synthetic HA available in the UK.
Invicta says that at 20mg per ml, SynVet-50 is also the most concentrated HA available.
Storage is at ambient temperature.
SynVet-50 is a 2.5ml solution containing 50mg HA, conveniently presented in a 5ml glass syringe.
Rob Watkins, Managing Director of Invicta said: "We are excited to be launching our first licensed medicine in the UK. The management team of Invicta have over 10 years experience in this market which has allowed us to provide a product strongly focussed on the clinicians needs, not just in terms of technical ability, but also in convenience of presentation".
For further information see www.invictavet.com or phone 01403 791313
Reference
Ceva Animal Health has published Causes of scour in growing pigs: an overview, a technical review on pig scour.
The company says its aim is to provides vets with an easy-reference guide to the main causes and clinical signs of this common and potentially fatal condition.
At best, scour in growing pigs can cause significant weight loss and damage to the intestinal mucosa. At worst it will result in high mortality. Causes of scour in growing pigs: an overview summarises the causative agents of scour throughout the stages of growth, from sucking piglets through to finisher pigs.
Ceva adds that although it is difficult to be too prescriptive about assigning clinical signs to specific diseases because of variable immunity and the occurrence of mixed infections, the review provides useful guidelines to aid accurate diagnosis. Preventative management strategies are also discussed where applicable.
For further product information contact your local Ceva representative or Ceva Animal Health Ltd, Unit 3, Anglo Office Park, White Lion Road, Amersham, Bucks, HP7 9FB, Telephone +44 (0) 1494 781510.
Stone Lion Veterinary Hospital, a first opinion and referral practice in Wimbledon, has announced that European Specialist in Veterinary Neurology Dr Sergio Rodenas, DVM DipECVN has joined the team to work alongside the Hospital's existing Veterinary Neurologist Dr Clare Rusbridge BVMS PhD DipECVN MRCVS RCVS and European Specialist in Veterinary Neurology.
The practice says that this will allow it to offer a full neurology referral service five days a week.
Sergio joins Stone Lion from his current post as Clinical Instructor in Neurology and Neurosurgery at the Veterinary College, St Hyacinthe at the University of Montreal. Before moving to Canada, he worked at the Southern Counties Veterinary Specialist (SCVS), a small animal specialist referral practice in Ringwood, Hampshire. He qualified at the Veterinary School, University of Extremadura, Spain, in 1996 and has also worked in both Spain and France.
The Stone Lion Veterinary Hospital is part of the Goddard Veterinary Group. It offers referrals in neurology, ophthalmology and physiotherapy. The Neurology Referral Practice is run by Clare Rusbridge and was established in 1997. She said: "Neurology is our busiest referral practice, drawing patients from across the South East of England and sometimes further afield. We see it as a growth area and wanted to offer our clients a five day a week service to make it easier for them to come to us. Sergio's experience especially in spinal surgery will be a huge asset to us and will enable us to meet this goal. We're delighted to welcome him."
Sergio added: "I am delighted to join the Neurology Service at the Stone Lion Veterinary Hospital. The facilities, team and professionalism of the staff and the track record of the Goddard Veterinary Group will make an excellent environment in which to practice small animal Neurology at the highest level and to offer the best care to patients."
The Stone Lion Veterinary Hospital can be contacted on 020 8946 4228.
The first opinion Linnaeus Group practice, which also holds RCVS hospital status, is run by a team of nine vets, 14 nurses, nine receptionists and four animal care assistants.
It was given an outstanding rating for client service, inpatient service, patient consultation service and team and professional responsibility.
Maureen Geraghty Sathi, Practice Manager at Maven said: "We’re always asking ourselves how could we do this better? Everyone has to be on board or it would not work."
The practice had a focus team look at awards and the improvements it would need to make to achieve the required standards. Amongst the various things that were highlighted as exceptional were:
A genuinely separate cat waiting area and cat consult room.
An extensive pain monitoring system with pain scoring for all patients in hospital and an outpatient system which enables clients to monitor and chart their pets pain levels at home and review them with their vet.
Daily clinical rounds which involve the entire clinical team as well as management and a member of the customer care team. Aside from discussing clinical cases for the day this platform also enables daily review of any significant events or morbidity and mortality cases to be highlighted and time allocated for review.
A system whereby vets at the practice email clients in advance of any surgical procedure with information on the procedure itself as well as any potential risks associated with the procedure allowing time for further discussion with the client as needed
Consistent use of surgical and GA checklists to maximise patient safety.
In the final report, the RCVS practice standards assessor wrote: "The structures and management in place were of the very highest order. I was really impressed by the commitment of this practice to provide the very highest standards of clinical care to its clients."
Maureen said: "I am massively proud of the team, to see the pride in how they work. It is lovely to be told that you are working to an extremely high level and genuinely reflects the standards of the team day by day."
The company says the new test overcomes a major shortcoming in faecal egg counts: that they can only detect the presence of egg-laying adult worms. The new test, by contrast, can detect all stages of the small redworm life cycle, including the important encysted larval phase.
ADB says the new test will help protect the effectiveness of moxidectin, the only dewormer which is capable of eliminating the encysted stages and against which widespread resistance is not thought to have developed.
Whereas before, routine winter treatment was needed to target the encysted phase, this new test means the drug can be kept for when it is really needed, which will help prevent the development of resistance. ADB says it will also be of great value to equine vets in making differential diagnoses.
The blood test was developed by Prof Jacqui Matthews’ group at the Moredun Research Institute (MRI), with funding from The Horse Trust. She said: "It is great to see the commercialisation of this much-needed test to support sustainable worm control in horses. The test fills an important gap in our diagnostic toolbox and will enable horse owners to work with their veterinarians in targeting anthelmintic treatments against cyathostomin infections and hence help protect these important medicines for the future."
Dr Corrine Austin from ADB said: "ADB is now developing laboratory ELISA kits to enable independent veterinary laboratories to conduct blood testing; these kits are expected to reach market during 2020. Research into the saliva-based test is ongoing and is expected to be commercialised several years from now."
Veterinary practices can contact ADB at info@austindavis.co.uk to register interest in the diagnostic test service.
The video has now been published on Youtube, from where veterinary practices might like to share it with clients on their own websites, by email or on their Facebook page.
In the video, Cat Henstridge MRCVS explains how from November, in the event of no deal, pet owners will need to have visited their vet 4 months before travel and had their pet vaccinated against rabies. They will then need to return for a blood test 30 days later, wait at least 3 months after that test before travel, and get an animal health certificate no more than 10 days before travel. In addition their animal needs to be microchipped.
Defra says owners should also be advised to visit gov.uk and search 'pet travel' for any updates.
Christine Middlemiss, UK Chief Veterinary Officer, said: "This is a reminder for pet owners of our practical and straightforward advice for pet travel if the UK were to leave the EU in a no-deal situation."
To watch and share the video: https://www.youtube.com/watch?v=8Ckhv5YS7Mw.
No word on the absolute number of 'concerns', but they included:
Jennie Jones, Head of VCMS and Partner at Nockolds Resolution (pictured right), said: "The COVID-19 pandemic and subsequent lockdown period has impacted many pet owners and veterinary practices. The increased use of remote consultations, and online and remote prescription services has been a great help to many during this time, but it also has its challenges as we all adapt to different ways of working. At the VCMS, we are well-equipped to take on complaints that eventuate in these circumstances, drawing on our past experience with prescription-related grievances and their resolution."
During 2018-19, the VCMS concluded 88% of complaints mediated using the ADR process developed by Nockolds.
Nockolds says it anticipates a rise in prescription-related complaints, and welcomes communication from practices and clients regarding these or any other vet-related complaints. Visit: http://www.nockolds.co.uk
The programme is comprised of one "Coffee with our Clinicians" session and two "Clinical Club evenings", both delivered using Microsoft Teams.
Paragon’s clinical director, Sophie Adamantos, said: "Coffee with our Clinicians is an opportunity to listen to two or more specialists discussing, and taking questions, on clinical cases and conundrums.
“Clinical Club will feature longer, more in-depth presentations by our clinicians from different disciplines discussing specific themes, treatments and developments."
The events are as follows:
To sign up for any of the CPD sessions, visit www.paragonreferrals.co.uk/veterinary-professionals/cpd
The forecast formed part of the Association's response to the Environment Food and Rural Affairs Committee (EfraCom) inquiry into the impact on the UK’s trade in food after Brexit.
The BVA says that if the UK is treated as a 'third country' post Brexit, exports and imports of animals and animal products to and from the EU will need new veterinary certifications.
The UK Chief Veterinary Officer, Nigel Gibbens, says the volume of products requiring veterinary certifications could increase by as much as 325% as a result.
There are currently 1,063 Official Veterinarians authorised by the Government’s Animal and Plant Health Agency (APHA) to certify food products for export to third countries from Great Britain, a number which the BVA says would have to be significantly increased.
The BVA is urging the Government to undertake a major review of third country certification to ensure we have the capacity to fulfil new trade agreements. To combat the potential shortage in veterinary capacity, BVA is also calling on the Government to guarantee working rights for non-British EU vets and veterinary nurses currently working and studying in the UK.
British Veterinary Association Senior Vice President, Gudrun Ravetz said: "Vets are absolutely vital to facilitating UK trade by ensuring standards so that consumers at home and abroad have confidence in the food safety and welfare of the products they choose to buy. Veterinary certification is required not only for meat, but a whole range of products such as gelatine in sweets.
"Ironically, it is non-British EU vets who make up around 50% of our new workforce each year. However, since the EU referendum, we are facing serious problems in recruiting and retaining EU vets, which makes the need for more vets to perform this crucial trade-task an even more pressing concern. Vets’ role in the future of UK trade must be recognised and planned for, as an integral part of forthcoming trade negotiations."
The BVA trade submission also outlines that access to veterinary medicines could potentially be restricted post-Brexit. In order to protect animal and public health, BVA is calling for any new trade deal with the EU to maintain the link with EU veterinary medicine approval systems.
The UK currently has high standards of animal health, animal welfare and public health, including food safety, in its food production. These standards help prevent the spread of pathogens and diseases in animal products, ensure farm animals have a humane death, protect food safety and safeguard responsible antimicrobial use. BVA’s submission to the EfraCom trade inquiry emphasises that, as public goods, the UK must prioritise the maintenance of these standards in all trade negotiations moving forwards.
BVA’s full response to the EfraCom inquiry into the impact on the UK’s trade in food after Brexit is available on the BVA website at www.bva.co.uk/news-campaigns-and-policy/consultations/consultation-responses/
The ‘Advances in Diabetes’ module, taking place at BSAVA Congress 2024 in Manchester Central, will offer delegates the chance to hear first-hand from the clinical researchers and specialists who have used these drugs, such as Dr Ellen Behrend, Prof Ian Ramsey, Prof Stijn Niessen, and Dr Anna Lena Kramer.
Stijn said: “Although not suited as a sole therapeutic for dogs, the current data suggests that a majority of diabetic cats could be treated with once daily oral formulations of these drugs.
“Some of the past barriers to successful long term diabetic treatment included the owner having to inject insulin twice daily and having to watch for hypoglycaemia.
"These lifelong impacts on the owner’s lifestyle are now being taken away.”
Delegates will also be able to learn about advances in the monitoring of canine diabetes, such as the use of Freestyle Libre monitors and haemoglobin A1c, as well as a review of recent developments and management practices for ‘complicated’ cases.
Stijn added: “Gone are the days that we saw diabetes mellitus as a disease; instead, it is the consequence of one or many diseases.
“As such we now ought to approach diabetic cases with a much more open mind and being willing to try and determine the exact aetiology of the diabetes mellitus, doing so can pay off and prevent a diabetic case from becoming a complicated case.”
Ellen added: “Although diabetic ketoacidosis is no more common with the use of SGLT2-inhibitors, it is more likely to be euglycemic with a blood glucose <13.9 mmol/L.
"The recognition of euglycemic ketoacidosis and the correct approach of treatment is crucial.”
Stjn concluded: “Each patient is an individual and therefore diagnosis, treatment and monitoring practices should be adapted to the individual pet-owner combination.
Vets must adjust their approaches significantly when using these drugs, the ‘Advances in Diabetes’ module will provide an in-depth look at these adjustments.”
Delegates will also be able to get their hands on the brand new fifth edition of the BSAVA Manual of Canine and Feline Endocrinology, which includes a chapter on feline diabetes mellitus that discusses various treatments including the use of SGLT2-inhibitors.
Jacquie Rand, author of the chapter said: “SGLT2-Inhibitors will be a game-changer for diabetic cats and their owners. However, it is important that cats are diagnosed earlier in the disease process while some insulin secretory capacity is present, for these to be used as the sole drug therapy.”
The BSAVA Manual of Canine and Feline Endocrinology will be available to purchase on the BSAVA Publications Stand in the Exhibition Hall. ‘Advances in Diabetes’ will take place on Thursday 21st March in the Exchange Hall.
Registration for BSAVA members starts at £115 +VAT for a one-day event pass.
https://www.bsavacongress.com.
Illustration: What a presentation about SGLT2-Inhibitors might look like (this has been photoshopped)
Having experienced the profession both as a clinician and as a director, Clive says he wanted to develop and integrate his skills to support fellow professionals. So, during lockdown, he embarked on a Master’s in Executive Coaching from Ashridge Hult Business School.
Clive said: "Studying for the Master’s was intellectually and emotionally tough. The emphasis was on psychology and relationships, working to the highest standards of ethical coaching practice. It has not only developed my coaching skills but also afforded me the opportunity to scrutinise the drivers and motivations behind my career choices and integrate them into a wider appreciation of life and my ‘self’. I am incredibly proud of this achievement and conscious of the privilege afforded me."
Clive's service typically involves six ninety-minute sessions during which he'll help you develop skills, behaviours and ways of behaving that will make you a better leader, particularly if you come from a clinical background where you'd be used to using very different skillset.
Clive, who is also a European Mentoring and Coaching Council Senior Practitioner, added: "In my practice as a coach, I am grateful for the opportunity to support others, whatever their life experiences, as they negotiate the challenges of being themselves, in the workplace, serving their communities.”
For more information, visit: www.trelliscoaching.co.uk
Dechra Veterinary Products has launched Ketodale, an anti-inflammatory injection for cattle, horses and swine.
Ketodale contains the non-steroidal anti-inflammatory drug ketoprofen 100mg/ml. It is indicated for use in cattle and swine for diseases associated with inflammation, pain or fever. In cattle these include respiratory diseases, mastitis, osteoarticular and muscular-skeletal disorders, such as lameness and arthritis, and to ease pain post parturition. Ketodale can be used to treat swine suffering from Mastitis Metritis Agalactia (MMA) Syndrome and respiratory tract infections.
In horses, Ketodale is indicated for diseases affecting the osteoarticular and muscular-skeletal system associated with pain and inflammation. These include naviculitis, arthritis and laminitis. It can also be used for post-surgical inflammation and symptomatic therapy of colic and fever.
Ketodale is available in 50ml and 100ml vials.
To coincide with the product's launch, Dechra is carrying out a direct marketing campaign. Practices can take advantage of a special launch offer where they can purchase four vials and get a fifth free. The offer is available for a limited period only.
To find out more about Ketodale, call Dechra on 01743 441 632 or visiting www.dechra.com
Woodley Equipment Company has announced that Veterinary Parasep Faecal Filters are now available exclusively from the company.
According to the Woodley, the filters have been developed in conjunction with an independent leading veterinary Institution and offer an improved method of determining Worm Egg Counts (WEC) on cattle, sheep and horses. Flotation methods for WEC can require several Specific Gravity solutions to cover different parasites. The two common flotation methods, ‘Modified McMaster' and ‘Improved Modified McMaster', both use Saturated NaCL and are both catered for with Veterinary Parasep.
Woodley says the key advantages of the new filters are:
For a more information about The Veterinary Parasep please email sales@woodleyequipment.com or call the customer service team on +44 (0) 1204 669033 ~ Option 1.
Alternatively, visit http://www.woodleyequipment.com/.
Sabrina joins Fran Taylor-Brown, Simon Bertram and head of service Tom Cardy.
Tom, a European and RCVS specialist in neurology, said Cave is now the biggest specialist-led neurology service in the South West:
“We are very pleased to have Sabrina join the neurology service at Cave, expanding our team to four European and RCVS-recognised specialists in veterinary neurology. This really sets Cave apart from our competitors.
“Sabrina’s arrival, in conjunction with the installation of our new state-of-the-art MRI scanner, means we can see most urgent neurology referrals within 24-48 hours in nearly all cases and increase the number of neurology cases we treat each day.”
Cave’s new £1.2m Phillips Ingenia 1.5T Evolution offers 50% faster scans at a far higher resolution than its previous MRI and shorter general anaesthetics for patients.
It also allows a more detailed and accurate diagnosis of complex neurological conditions.
Tom added: “The MRI scanner is one of the most advanced imaging modalities for the nervous system, providing millimetre-thick cross-sectional images of the brain and spinal cord which is essential for both accurate diagnosis and treatment.
“Having such advanced equipment and facilities plus four recognised specialists means all our clients and their pets will see a vet with the highest level of training in veterinary neurology.
“All of our specialists are happy to discuss challenging cases on the phone with our referring vets and Sabrina's skills and enthusiasm will continue to improve and diversify the service we offer.
https://cave-vet-specialists.co.uk
Zoetis says the new product is designed to stimulate both cell-mediated and antibody-based immunity, providing a broad immune response that mimics a natural infection.
The company says CircoMax Myco has demonstrated robust performance in field conditions, delivering improvements in average daily gain (ADG) and close-out weights versus negative controls, helping producers get more kilograms of pork to market.
CircoMax Myco comes in a ready to use single-dose combination with a duration of immunity (DOI) of 23 weeks against both PCV2 and M. hyopneumoniae.
Alvaro Aldaz, Director, Global Commercial Development, Swine, Zoetis, said: “The swine industry needs to adapt to evolving challenges and our research has consistently demonstrated that with its unique technology CircoMax Myco offers robust protection against PCV2 and M. hyopneumoniae.
"It also shows that this new product offers the best chance at protection against continuously evolving PCV2 genotypes – providing a broader umbrella for pig health and productivity.
"Analysis of new European PCV2 strains isolated in multiple countries confirm that CircoMax Myco offers broader coverage than competitor vaccines based on PCV2a only.”
The dentistry group is one of a number of special interest groups being launched on VetSurgeon.org in the coming months which ALL members are invited to come and join.
The new groups make it much easier to find and follow content that interests you. More than that, they bring together members with a shared interest in the subject, thereby facilitating the sharing of information, experience and knowledge. To that end, expert contributors to the new dentistry group include: Pete Southerden, Norman Johnston, Bob Partridge and Evelyn Barbour-Hill.
As elsewhere on VetSurgeon.org, reading content in the new groups or participating in discussions can count towards a VetSurgeon.org CPD certificate. Just press 'Claim CPD' at the top of the page, then collect the record and certificate from your profile.
As elsewhere on VetSurgeon.org, there's also the opportunity for you to express your appreciation of shared information you've found helpful, by pressing the 'Thank you' button above content. We'll be rewarding those members who are most thanked by members of the site for their help.
The new groups have been set up partly in response to the growth in Facebook groups for vets and the need for VetSurgeon.org to offer added value over Facebook if it is to compete for your attention.
By virtue of the number of its numbers, Facebook probably can't be beaten for general 'chit chat'. But for clinical discussions, it has some serious flaws.
Firstly, there's minimal curation of content and it's more or less impossible to filter irrelevant stuff. Because of that, and because Facebook displays post excepts, rather than headlines, you can end up having to scroll as far as Australia to find stuff relating to your area of interest.
By contrast, the listings of latest content by title on VetSurgeon makes it much easier to scan the content and find the stuff that interests you, particularly now content is grouped by clinical discipline.
Perhaps even more importantly, it's impossible to see the professional qualifications of the person who replied to you on Facebook, so you don't necessarily know if they have the faintest idea what they are talking about. VetSurgeon profiles are visible to all, and allow members to display their postgrad veterinary qualifications, amongst other things.
Lastly, the way discussions on Facebook are 'threaded' makes it very, very difficult to refer back and find who said something useful (you remember someone said something, but then, on a busy thread, you may have to expand 20 or 20 threads to find the thing you were after). That's not just a pain in the derrière, it means that any valuable information shared by specialists and experts is too easily lost.
The bottom line is that if you're looking for general chat, Fleecebook may be your best bet. But if you have questions about specific clinical disciplines, VetSurgeon.org is where you'll find better answers, quicker.
The vaccine will be available to order directly from Merial on receipt of a Special Import Certificate (SIC) issued by the VMD to the named vet. The SIC is only required once but needs to accommodate all potential doses required, enabling Merial to supply to direct orders from the practice.
The product is available in 10 dose packs at a net price of £89.00 per pack.
For further information, contact Merial Customer Support Centre (UK) on 0870 6000 123 or your local equine territory manager.
The partnership includes a minimum donation of £10,000 which the company hopes to bolster with additional volunteering and fundraising support.
Gerard Ensink, Head of Animal Health UK and Ireland at Boehringer Ingelheim said: “We are truly delighted to be supporting StreetVet.
“There is already so much passion for the charity within our company.
"Even before we announced this charity partnership, several of our colleagues have been volunteers with StreetVet in a personal capacity.
"We look forward to supporting StreetVet and believe that together we can make a real difference to individuals and their pets who are experiencing homelessness.”
https://www.streetvet.co.uk
TVM says DogStem, which is currently the only UK/EU-licensed stem cell treatment for this condition, is clinically proven to reduce pain and lameness while improving mobility and quality of life for dogs over one year.
The training materials include downloadable teaching guides and two videos fronted by Dr Russell Chandler BVSc CertSAO MSc(OrthoEng) MRCVS, an Advanced Practitioner in Small Animal Orthopaedics (pictured).
The videos are designed to help GP vets become more confident about performing intra-articular injections in the hip and elbow, sharing principles and techniques which are also useful for performing arthrocentesis.
Specifically, the videos show the precise procedures, in both elbow and hip, for accessing joint spaces, confirming accurate placement by the appearance of synovial fluid and injecting DogStem.
The training guides offer supporting diagrams and explanations of the approaches to each joint.
Russell, who works at Alphavet Referrals in Newport, Gwent said: “We are proud to have been involved in the production of these training videos, which will support veterinary clinicians everywhere in providing pioneering stem cell treatment to improve the quality of life of dogs suffering from osteoarthritis.
“We have been using mesenchymal stem cell therapy for dogs with osteoarthritis, as part of a multimodal approach, for many years.
"The availability of an off-the-shelf stem cell product, namely DogStem, for the first time promises to greatly widen the applicability of stem cell therapy to these kinds of patients in veterinary practices.
“The early responses to treatment that we have seen with DogStem have been very encouraging.
"I look forward to following up these cases as they progress through their osteoarthritis journey.
"DogStem is simple to administer, once you have the skills to inject joints, and the support from the UK suppliers, TVM, has been excellent."
https://dogstem.co.uk/resources
The Dairy Vet of the Year award, which is organised by the British Dairying Magazine and sponsored by Krka UK Ltd, recognises a veterinary surgeon for going the extra mile in helping to create a more positive, forward-thinking dairy industry.
In addition to her work as a farm vet, Sarah is also Technical Director at the TB Advisory Service (TBAS), which involves her overseeing and delivering training for new advisors, chairing technical board meetings and delivering farmer meetings across the country. She also provides bespoke advice to farmers in High Risk and Edge Areas of England, and is known for her compassion and understanding for those suffering a TB breakdown.
She is also a member of the TB Eradication and Advisory Group (TBEAG) for England, which advises government policy makers on all aspects of TB control in England.
Lindsay Heasman, Project Manager at TBAS, said: “Sarah is an authority on TB and understands the responsibility that comes with this role. She uses her position for good at all times and is prepared to make statements that are not always universally popular. By standing by her beliefs and dispelling misconceptions, she has won the respect of farmers across the country. Her dedication has, at times, come at personal cost, but her passion for eradicating bTB and support for farmers in achieving this goal never wavers.”
Sarah said: “I am just a farm vet doing the same job every farm vet does daily across the country. Through necessity, seeing my clients being devastated by TB breakdowns every day, I felt passionate about doing something about it. TBAS, my colleagues I am lucky to work with, and TBEAG have given me the platform to do this. I am very humbled that the judges though me worthy of the Award amongst the other hard-working vets."
Photo: Giles Brandreth, Charlotte Read, Sarah Tomlinson and Sean Sparling
Norbrook Laboratories Ltd has launched a second generation Eprinomectin Pour On solution with zero milk withhold and a 10 day meat withdrawal period. Eprizero, for beef and dairy cattle, is indicated for the treatment and prevention of a range of economically damaging gutworm and lungworm infections and external parasites in a pour on application. It offers zero milk withhold and an improved meat withdrawal period of 10 days. Andrew Hillan MVB MRCVS, Director of Veterinary Science, Norbrook Laboratories Ltd., said: "Norbrook has launched Eprizero to offer vets and farmers a more versatile alternative in the treatment of economically damaging worms and external parasites. The active ingredient in Eprizero, Eprinomectin, is both potent and fast-acting and is supported by independent studies which show increased milk yield, improved fertility and increased dry matter intake following treatment. With a zero milk and 10 day meat withdrawal and waterproof properties, Eprizero offers real versatility to vets and farmers in terms of when and where they treat. It is this versatility that we believe will make Eprizero the gold standard in anthelmintic treatment for prolonged infestations of gut worm and lung worm in both dairy and beef cattle." Eprizero is available in four sizes - 250ml, 1L, 2.5L and 5L - with a free 75ml gun supplied with the two larger pack sizes. It is administered using a 75ml dispensing gun to enable accurate application. Eprizero is registered for use in the UK and Ireland and is available to order from your local Norbrook Sales Representative.
An amendment to the EU's draft budget for a €2 million pilot research project into homeopathy and phytotherapy for farm animals has been approved today by the European Parliament's Agriculture Committee.
BVA President Harvey Locke, said: "Millions of Euros have already been spent on trying to prove the scientific efficacy of homeopathic medicines. To date we have not seen any data to prove they can be effective in the treatment of bacterial infections.
"Whilst it is unlikely that €2 million will be able to determine whether or not there is a basis for claiming homeopathic products can work, we welcome European investment in veterinary research and hope that the results of the pilot will be useful."
Janssen Animal Health has produced a new DVD called 'Fluke: That's a Fact', which is available free from the company.
The 18 minute film features TV presenter Michaela Strachan discussing the big issues surrounding fluke in sheep, such as the effects on productivity and fertility and the need to adapt treatment regimes to reflect the current challenge in the environment, weather patterns and the possibility of resistance to commonly used flukicides. There is also a section on Haemonchus, the Barber's Pole worm, as the parasite has been reported in a number of farms in the last few years.
According to the company, fluke is becoming increasingly common and is moving into new areas of the UK. There is increasing evidence that a single autumn / winter dose of flukicide may not always be enough to control the disease on some farms and more frequent dosing programmes are now often proposed that look more long term to reduce the level of the disease on farms, especially on those farms with high infection pressure. The film clearly explains these different approaches and the benefits of treating at various times of the year.
Janssen's Livestock Marketing Manager Nigel Underwood hopes the film will be a great educational tool that will help both farmers and SQPs better understand the disease: "With ten easy to watch sections, people will be able to listen to the whole story or just dip into those areas where they feel they need to know more. With her long standing interest in the countryside and wildlife, Michaela Strachan was the perfect choice to present what can be a rather complex story and I'm sure everyone will enjoy her clear explanation of the facts."
To request a DVD or for further information, please contact Janssen Animal Health, 50-100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG. Tel 01494 567555 Fax 01494 567556 Email: ahealth@its.jnj.com www.janssenanimalhealth.com/uk
The procedure is called radiocatheter ablation. It's used regularly in humans but there are only three or four centres in the world that perform the procedure routinely on veterinary patients and Pedro is the only veterinary cardiologist currently performing it in the UK.
DVS says the procedure can achieve a cure for previously incurable conditions, without the need for further medical treatment with drugs that have potential side effects. It involves inserting catheters into veins in the legs and neck and then guiding them into the heart. Electrical signals can be recorded to show where the abnormal heartbeats are generated ('mapping'). Once this is achieved, heat is used to destroy the tiny abnormal area of the heart muscle and make the arrhythmia disappear ('zapping'). Recovery is straightforward and the condition can be completely cured.
Jake, a three-year-old Labrador Retriever, is one of seven dogs that have been cured by Pedro and the team so far.
Jake suffered from life-threatening cardiac arrhythmia, causing his heart to beat at over 250 beats per minute for prolonged periods. Such an elevated heart rate cannot be sustained for long and may result in damage to the heart muscle. Jake had been diagnosed a number of months ago and initially responded to anti-arrhythmic drugs. However, the drugs stopped working and his heart was sustaining damage and showing early signs of weakness. The radiocatheter ablation cured his condition completely and he can now lead a normal healthy life.
Jake’s owner, Mrs Chapman from Staffordshire, said: "We would like to thank everyone at Davies Veterinary Specialists for looking after Jake during his three day stay in April 2016. Special thanks to Pedro Oliveira and his cardiac team for operating on Jake and correcting his heart condition. Jake is no longer taking any medication and has made a full recovery. We now have a much happier, more energetic Labrador, ready for walks and play at every opportunity. Jake seems to have a smile on his face everyday now and is enjoying life to the full."
Pedro said: "We have treated seven patients in the past year, all with success and without complications. Unfortunately a significant proportion of candidates for these procedures are in desperate situations with failing hearts and after all drugs have failed before they reach us. Hopefully, with greater awareness of the availability of this procedure, we can treat more patients before it gets to be that bad."
Clive Elwood, Managing Director of Davies Veterinary Specialists said: "This is a great example of how our team of specialists can deliver ground-breaking and innovative care, which makes a real difference for both patients and their loving owners."
Pedro is happy to discuss the suitability of cases with vets managing dogs with arrhythmias. Contact him at cardiology@vetspecialists.co.uk or find out more at www.vetspecialists.co.uk